If you are a registered attendee, you can view the OnDemand sessions for 90 days by clicking the OnDemand banner at the top of this page.
If you did not attend the live virtual event, you can still register for the OnDemand sessions by clicking the OnDemand banner at the top of this page.
ePosters and moderated ePosters are open access and available to all. Click on the “Access ePosters” button on the right side of this page.
Zugui Zhang | Christina Care Health System, Newark, Deleware
- RESULTS: Multiple scenario analyses found lifetime cost-effectiveness of icosapent ethyl ($4.64/day) compared to standard care.
- Zhang's Abstract
Patient-Reported Outcomes, Resource Utilization, and Health Care Expenditures Across the 3 Major Atherosclerotic Diseases: The Medical Expenditure Panel Survey (meps)
Martin Tibuakuu | St. Luke's Hospital, Ballwin, Missouri
- RESULTS: Compared to CAD, stroke and PAD were associated with lower use of guideline-directed preventive therapies, highlighting a missed opportunity for secondary ASCVD prevention in these patients.
- Tibuakuu's Abstract
Impacts of the Million Hearts® Cardiovascular Disease Risk Reduction Model on the Initiation or Intensification of Statins and Anti-Hypertensive Medications: A Pragmatic, Cluster-Randomized Trial
G. Greg Peterson | Mathematica Policy Research, Washington, DC
- RESULTS: Use of CVD medications significantly improved with the Million Hearts® model, especially in high-risk participants and increased provider awareness of risk.
- Peterson's Abstract
Social Determinants of Health and Participant Retention in a Disparities Study and Primary Care: Findings From the Hypertension and Values (hyvalue) Trial
Kamal Henderson | Rocky Mountain VA Medical Center, Denver, Colorado
- RESULTS: Higher social determinants of health levels associated with less research study retention.
- Henderson's Abstract
Andy T. Tran | Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Missouri
- RESULTS: Discordance noted between patient-reported and physician estimates of angina. Tools that include the patient's outcome measures may help select those who will have QOL benefits after PCI.
- Tran's Abstract